Pegvaliase Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with pegvaliase
P
- pegademase bovine
- pegaptanib ophthalmic
- pegaspargase
- Pegasys (peginterferon alfa-2a)
- pegcetacoplan
- pegcetacoplan ophthalmic
- pegfilgrastim
- peginesatide
- peginterferon alfa-2a
- peginterferon alfa-2b
- peginterferon beta-1a
- PegIntron (peginterferon alfa-2b)
- pegloticase
- pegunigalsidase alfa
- pegvisomant
- Pfizer-BioNTech COVID-10 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 12y+) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (12y+) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna(tozinameran12y+) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 308) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308))
- Pfizer-BioNTech COVID-19 (2023-2024) Vaccine PF (cvx 310) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310))
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 5y-11y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Bivalent Vaccine PF (sars-cov-2(covid-19)mrna(tozinameran 5y-11y)bivalent vaccine)
- Pfizer-BioNTech COVID-19 (5y-11y) Vaccine PF (sars-cov-2 mrna (tozinameran 5y-11y) vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent booster vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Bivalent Vaccine PF (sars-cov-2 (covid-19) mrna (tozinameran 6m-4y) bivalent vaccine)
- Pfizer-BioNTech COVID-19 (6m-4y) Vaccine PF (sars-cov-2 mrna (tozinameran 6m-4y) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (Do Not Dilute) (sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine)
- Pfizer-BioNTech COVID-19 Vaccine (sars-cov-2 mrna (tozinameran) vaccine)
- Plegridy (peginterferon beta-1a)
- Premphase (conjugated estrogens / medroxyprogesterone)
- Premphase 14 / 14 (conjugated estrogens / medroxyprogesterone)
- Prempro (conjugated estrogens / medroxyprogesterone)
- Provera (medroxyprogesterone)
More about pegvaliase
- pegvaliase consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.